NCAM1 and kidney disorder: Since aberrant NCAM/FGFR signaling is equally present among various human renal diseases especially at the beginning of renal interstitial fibrosis [15, 16], and TGF-β1 is considered as master inducer of fibrogenic responses in the kidney, our current findings could have significant translational implications.